STEPHANNIE LEGARRETTA: Open Payments
NPI 1801537790 · HORIZON CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,510 in 110 payments from 17 companies in 2025. Trend: 2023 $2,006 · 2024 $1,875 · 2025 $2,510
Food & beverage: $2,499Travel & lodging: $11
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $1,018 |
| UCB, Inc. | 12 | $348 |
| Amgen Inc. | 21 | $347 |
| AstraZeneca Pharmaceuticals LP | 5 | $256 |
| GlaxoSmithKline, LLC. | 3 | $147 |
| Novartis Pharmaceuticals Corporation | 4 | $111 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| Aurinia Pharma U.S., Inc. | 2 | $45 |
| Radius Health, Inc. | 2 | $36 |
| PFIZER INC. | 1 | $24 |
Products named: RINVOQ, SKYRIZI, Bimzelx, SAPHNELO, TAVNEOS, BENLYSTA, COSENTYX, OTEZLA.
Industry payments across TX — which companies pay providers there.
